Genetic and clinical study of myeloperoxidase's association with coronary artery disease

The Egyptian Heart Journal

Table 3 Correlation between serum MPO levels and some parameters

Serum MPO level	Spearman correlation (r)	95% confidence interval	P-value	P-value summary
Age	− 0.08491	− 0.2821 to 0.1192	0.4010	ns
BMI	0.05769	− 0.1461 to 0.2568	0.5686	ns
GPT	0.009310	− 0.1931 to 0.2110	0.9268	ns
GOT	− 0.1023	− 0.2982 to 0.1019	0.3114	ns
urea	0.003468	− 0.1987 to 0.2054	0.9727	ns
Creatinine	− 0.2576	− 0.4369 to − 0.05859	0.0097	**
Total Bilirubin	− 0.2416	− 0.4230 to − 0.04153	0.0155	*
Alp	0.1817	− 0.02113 to 0.3702	0.0704	ns
LDH	0.006442	− 0.1959 to 0.2082	0.9493	ns
Glucose	0.2140	0.01250 to 0.3988	0.0325	*
Cholesterol	− 0.008797	− 0.2105 to 0.1936	0.9308	ns
TG	0.0001952	− 0.2019 to 0.2023	0.9985	ns
HDL	− 0.1250	− 0.3190 to 0.07911	0.2155	ns
LDL	− 0.07143	− 0.2696 to 0.1325	0.4800	ns
CRP	0.1777	− 0.02525 to 0.3666	0.0769	ns
CKmB	0.1223	− 0.08178 to 0.3166	0.2254	ns
Troponin	− 0.07771	− 0.2755 to 0.1263	0.4422	ns

BMI, body mass index; GPT, Glutamic Pyruvic Transaminase; GOT, glutamic-oxaloacetic transaminase; Alp, Alkaline phosphatase; LDH, Lactate dehydrogenase; TG, Triglycerides; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; CRP, C-reactive protein; CKmB, creatine kinase-myoglobin binding. *Statistical significance